濮阳东方看妇科病口碑很好价格低濮阳东方医院妇科做人流收费非常低,濮阳东方男科医院在哪,濮阳东方医院妇科做人流好吗,濮阳东方男科看病专业吗,濮阳东方男科医院割包皮口碑很好价格低,濮阳东方技术非常专业,濮阳东方妇科医院挂号电话

The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn’t need any special computer equipment to get results.The 15-minute test from Abbott Laboratories will sell for , giving it a competitive edge over similar tests that need to be popped into a small machine. The size of a credit card, the self-contained test is based on the same technology used to test for the flu, strep throat and other infections.It’s the latest cheaper, simpler test to hit the U.S. market, providing new options to expand testing as schools and businesses struggle to reopen and flu season approaches. The FDA also recently greenlighted a saliva test from Yale University that bypasses some of the supplies that have led to testing bottlenecks.Both tests have limitations and neither can be done at home. Several companies are developing rapid, at-home tests, but none have yet won approval. Abbott’s new test still requires a nasal swab by a health worker, like most older coronavirus tests. The Yale saliva test eliminates the need for a swab, but can only be run at high-grade laboratories.And in general, rapid tests like Abbott’s are less accurate than lab-developed tests. The FDA said in a statement announcing the decision that negative results with Abbott’s test may need to be confirmed with a lab test in some cases. The agency granted Abbott’s test an emergency use authorization late Wednesday for patients with suspected COVID-19.The two additions should help expand the number of available tests. The U.S. is now testing about 690,000 people per day, down from a peak of 850,000 daily tests late last month. Many public health experts believe the country will soon need to test vastly more people to find those who are infected, isolate them and contain the virus.The FDA noted that Abbott’s test could be used in a doctor’s office, emergency room or some schools. “Given the simple nature of this test, it is likely that these tests could be made broadly available,” the FDA said.Since the start of the pandemic, nasal swab tests that are sent to a lab have been the standard for COVID-19 screening. While considered highly accurate, the tests rely on expensive, specialized machines and chemicals. Shortages of those supplies have led to repeated delays in reporting results, especially during a spike in cases last month.Government and health experts view rapid tests that can be run outside the laboratory system as key to boosting capacity.“Those screening tests are what we need in schools, workplaces and nursing homes in order to catch asymptomatic spreaders,” said Dr. Jonathan Quick of the Rockefeller Foundation, in an interview earlier this month. The nonprofit group has called for the U.S. to conduct about 4 millions per day by October, mostly rapid, point-of-care tests.Abbott’s BinaxNOW is the fourth rapid test that detects COVID-19 antigens, proteins found on the surface of the coronavirus, rather than the virus itself. It’s considered a faster, though sometimes less precise, screening method. The other tests need to be inserted into a small machine.Inside the Abbott test is a specially coated strip that interacts with COVID-19 antigens. The patient’s nasal swab is inserted into the card and a few drops of a chemical solution are added. Markings appear on the card to indicate whether the sample is positive or negative — much like a pregnancy test.Two other makers of antigen tests — Quidel and Becton Dickinson have said they haven’t been able to meet demand for the tests. A third, LumiraDx, plans to begin shipping its recently approved antigen tests by the end of this month. Abbott expects to begin shipping tests in September, reaching 50 million tests a month in October.The influx of antigen tests will go a long way toward meeting the Trump administration’s projection that 90 million COVID-19 tests a month will be available by September if needed. But U.S. “testing czar” Adm. Brett Giroir has stressed that the U.S. can contain the outbreak with far fewer tests.“That’s the capacity ... we do not need that many tests to safely and sensibly reopen,” Giroir told reporters on a recent call. He pointed to several key indicators that have been falling, including new infections and hospitalizations, even as testing has slowed.Earlier this month, the FDA authorized Yale’s saliva-based test, which is expected to cut the time and cost compared with similar tests. It’s the fifth COVID-19 saliva tests OK’d by regulators. All require lab processing.Developed by Yale’s School of Public Health, SalivaDirect can use any sterile container to collect a sample, not the special tube needed with earlier tests, and requires less chemicals. Outside experts welcomed the new approach but noted its limitations.“It’s not a rapid test, it’s a laboratory-based test that will still be prone to the same massive delays as any other test,” said Dr. Michael Mina of Harvard University.___Follow Matthew Perrone on Twitter: @ AP_FDAwriter.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5201

The Dow Jones Industrial Average continued its volatile run on Monday, closing down 200 points. At one point during the day, the index was about 350 points above its previous close.Struggling tech stocks and fears about trade tariffs have led to selling sprees in the past month. The market is down about 2,000 points from where it opened in October.More on this as it develops. 391

The Department of Justice said Monday that an NYPD officer had been arrested and charged with allegedly acting as an "illegal agent" for the Chinese government.In a statement released Monday, the DOJ said that in addition to illegal agent charges, 33-year-old Baimadajie Angwang has also been charged with committing wire fraud, making false statements and obstructing an official proceeding.The DOJ alleges that Angwang was providing information about Chinese citizens in the New York area to the government of the People's Republic of China. He was also allegedly "developing intelligence sources within the Tibetan community."According to Scripps station WPIX in New York, Angwang is a Tibetan native and resident of Long Island. He worked in the NYPD's 111th precinct in Queens and was also employed by the U.S. Army Reserve as a staff sergeant.Angwang initially arrived in the U.S. on a cultural exchange visa. Once that visa was renewed, he overstayed the length and later claimed asylum "on the basis that he had allegedly been arrested and tortured" in China due to his Tibetan heritage.A complaint alleges that Angwang has worked under the control of the Chinese government since 2014. He allegedly told his Chinese government handler that he wanted to be promoted within the NYPD "so that he could assist the PRC and bring 'glory to China.'""As alleged in this federal complaint, Baimadajie Angwang violated every oath he took in this country. One to the United States, another to the U.S. Army, and a third to this Police Department," NYPD Commissioner Dermot Shea said. "From the earliest stages of this investigation, the NYPD's Intelligence and Internal Affairs bureaus worked closely with the FBI's Counterintelligence Division to make sure this individual would be brought to justice.""The defendant allegedly violated the trust of his community and the New York City Police Department on behalf of a foreign power, the People's Republic of China. This type of conduct simply cannot be tolerated," said Alan E. Kohler, Jr., Assistant Director of the FBI's Counterintelligence Division. "This case serves as yet another reminder that China represents the biggest counterintelligence threat to the United States and that the FBI and our partners will be aggressive in investigating and stopping such activities within our nation."If convicted, Angwang faces a maximum of 55 years in prison. 2412

The fatal New York City helicopter crash that killed everyone on board except the pilot may have been caused by a passenger's piece of luggage, the pilot told investigators.The pilot said one of the passenger's bags may have inadvertently hit the emergency fuel shutoff button, leading to the crash that killed five passengers, a senior law enforcement official said.The National Transportation Safety Board will try to determine the cause of the Sunday evening crash, the Federal Aviation Administration said. The NTSB tweeted that an investigation team of 14 people would arrive Monday morning.  610

The COVID-19 death of the speaker of the New Hampshire House of Representatives has raised fears that other members of one of the world's largest legislatures might have been exposed at their swearing-in ceremony last week. A medical examiner announced the cause of death Thursday of 71-year-old Dick Hinch. Hinch was found dead in his home.He was photographed at the outdoor swearing-in wearing a mask improperly, without it covering both his nose and mouth. Dozens reportedly attended without wearing masks at all. Several Republican lawmakers have tested positive after attending an indoor meeting in late November where many attendees didn't wear masks. One Republican representative says Hinch's death may be a result of “peer pressure exerted by those in the Republican Party who refuse to take reasonable precautions."At a news conference Thursday, New Hampshire Governor Chris Sununu, a fellow Republican, called Hinch a "tireless leader" and close friend. He then said Hinch's death was a "cautionary tale" about not wearing a mask properly.“For those who are just out there doing the opposite just to make some ridiculous political point, it is horribly wrong,” Sununu said. “Please use your heads. Don’t act like a bunch of children, frankly.”Other state Republicans were harsher in their messaging. Representative William Marsh, a retired doctor, posted on Twitter, “Those in our caucus who refused to take precautions are responsible for Dick Hinch’s death." 1479